Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
Clinical trial NCT03694353 · COMPLETED
Trial details
- NCT number
- NCT03694353
- Sponsor
- BioMarin Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-13
- Primary completion
- 2021-01-13
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.